In Ptprz1−/− mice, the number of mature B-cells is decreased [137], raising the hypothesis that this might be a mechanism through which PTPRZ1 affects cancer development depending on the inherent immunogenicity of each tumor. This evidence concerns the gene PTPRZ1 and neoplasm.